Pentamaster diversifying into medical device business


Pentamaster chairman CB Chuah (pic) told StarBiz that the group was now in the process of submitting application to get approvals from the US-based Food & Drugs Agency (FDA) and Malaysian Drug Agency (MDA) for the business.

GEORGE TOWN: Semiconductor test equipment maker Pentamaster Corp Bhd is investing over RM100mil over the next three years in a medical device plant as the company seeks to diversify into the medical device business to broaden its revenue base.

Group chairman CB Chuah told StarBiz that the group was now in the process of submitting application to get approvals from the US-based Food & Drugs Agency (FDA) and Malaysian Drug Agency (MDA) for the business.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Gold rises on weaker oil; inflation, rate outlook in focus
CIMB says ‘good time’ to invest in battered Indonesia, seeks M&A
Indonesian rupiah strengthens after surprise BI rate hike
Shipbuilder speeds up its green transition
China's yuan firms on softer dollar, solid trade data
Malaysia eyes nearly RM800bil in electronics exports in 2026
Oil falls as investors await clarity after Iran-Israel halt attacks
Bursa Malaysia trades flat at lunch break amid cautious sentiment
Maybank steps up support for SMEs affected by West Asia conflict
Indonesia’s five-year bond yield climbs to highest since 2020

Others Also Read